CORC  > 山东大学
Targeting dopamine receptor 2 (DRD2) signaling in combination with temozolomide chemotherapy as a novel therapeutic concept in glioblastomas.
Johannessen, Tor-Christian Aase; Grudic, Amra; Zhu, Huaiyang; Saed, Halala; Varughese, Jobin; Yang, Ning; Sundstrom, Terje; Janji, Bassa 更多
2015
会议名称Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer
会议日期MAY 29-JUN 02, 2015
卷号33
期号15
收录类别CPCI-S ; SCIE
会议录JOURNAL OF CLINICAL ONCOLOGY
URL标识查看原文
内容类型会议论文
URI标识http://www.corc.org.cn/handle/1471x/6035940
专题山东大学
作者单位1.[Johannessen, TCA
2.Grudic, A
3.Zhu, HY
4.Saed, H
5.Varughese, J
6.Yang, N
7.Sundstrom, T
8.Janji, B
9.Wang, J
10.Lund-Johansen, M
推荐引用方式
GB/T 7714
Johannessen, Tor-Christian Aase,Grudic, Amra,Zhu, Huaiyang,et al. Targeting dopamine receptor 2 (DRD2) signaling in combination with temozolomide chemotherapy as a novel therapeutic concept in glioblastomas.[C]. 见:Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer. MAY 29-JUN 02, 2015.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace